Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,887 | -15,643 | -6,755 | -25,202 | -19,345 |
| Depreciation Amortization | 51 | 34 | 17 | 50 | 32 |
| Other Working Capital | 6,360 | -308 | -525 | 2,536 | 2,257 |
| Other Operating Activity | 2,099 | 736 | 334 | 871 | 613 |
| Operating Cash Flow | $-17,377 | $-15,181 | $-6,929 | $-21,745 | $-16,443 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 24,124 | 24,124 |
| PPE Investments | N/A | N/A | N/A | -4 | -4 |
| Other Investing Activity | -424 | -321 | -139 | -569 | -423 |
| Investing Cash Flow | $-424 | $-321 | $-139 | $23,551 | $23,697 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 878 | 9 | N/A | 15,885 | 327 |
| Financing Cash Flow | $878 | $9 | $N/A | $15,885 | $327 |
| Beginning Cash Position | 19,470 | 19,470 | 19,470 | 1,779 | 1,779 |
| End Cash Position | 2,547 | 3,977 | 12,402 | 19,470 | 9,360 |
| Net Cash Flow | $-16,923 | $-15,493 | $-7,068 | $17,691 | $7,581 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,377 | -15,181 | -6,929 | -21,745 | -16,443 |
| Capital Expenditure | N/A | N/A | N/A | -4 | -4 |
| Free Cash Flow | -17,377 | -15,181 | -6,929 | -21,749 | -16,447 |